Given the potential toxicity of targeting nAChR or Src46,47, the inhibition of the RA system by ACE inhibitors or AGTR1 antagonists that are prescribed to hypertensive patients without major complications would be an effective strategy for the prevention of lung cancer in smokers. The gene discussed is ACE; the disease is lung carcinoma.